Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 607-864-3
CAS number: 26116-57-4
"Erythromycin, 9-oxime, monohydrochloride" is an intermediate of the
patients receiving systemically administered azithromycin, serious
allergic reactions, including angioedema, anaphylaxis, and dermatologic
reactions including Stevens-Johnson syndrome and toxic epidermal
necrolysis have been reported rarely in patients on azithromycin
therapy. Although rare, fatalities have been reported. The potential for
anaphylaxis or other hypersensitivity reactions should be considered
based on known hypersensitivity to azithromycin when administered
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Sellel veebilehel kasutatakse küpsiseid, et tagada lehe parim kasutus.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again